“Internet-delivered treatment for substance abuse: a multisite randomized controlled trial.”, Am J Psychiatry, vol. 171, no. 6, pp. 683-90, 2014.
, “Performance of the Tobacco, Alcohol, Prescription Medication, and Other Substance Use (TAPS) Tool for Substance Use Screening in Primary Care Patients.”, Ann Intern Med, vol. 165, no. 10, pp. 690-699, 2016.
, “Comparing adult cannabis treatment-seekers enrolled in a clinical trial with national samples of cannabis users in the United States.”, Drug Alcohol Depend, vol. 176, pp. 14-20, 2017.
, “A randomized placebo-controlled trial of N-acetylcysteine for cannabis use disorder in adults.”, Drug Alcohol Depend, vol. 177, pp. 249-257, 2017.
, “Effect of Oral Valproic Acid vs Placebo for Vision Loss in Patients With Autosomal Dominant Retinitis Pigmentosa: A Randomized Phase 2 Multicenter Placebo-Controlled Clinical Trial.”, JAMA Ophthalmol, vol. 136, no. 8, pp. 849-856, 2018.
, ,
“Bupropion and Naltrexone in Methamphetamine Use Disorder”, N Engl J Med, vol. 384, no. 2, pp. 140-153, 2021.
, “Comparison of Methods for Alcohol and Drug Screening in Primary Care Clinics”, JAMA Network Open, vol. 4, no. 5, p. e2110721, 2021.
, “Successful Implementation of Substance Use Screening in Rural Federally-Qualified Health Centers Identified High Rates of Unhealthy Alcohol, Cannabis, and Tobacco Use”, in The College on Problems of Drug Dependence (CPDD), Minneapolis, MN, 2022.
,